Matthews Andrea's most recent trade in Astria Therapeutics Inc was a trade of 262,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Astria Therapeutics Inc | Andrea Matthews | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 262,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
Astria Therapeutics Inc | Matthews Andrea | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Astria Therapeutics Inc | Andrea Matthews | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Astria Therapeutics Inc | Andrea Matthews | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |